Home › Funds › ACT CAPITAL MANAGEMENT, LLC › PALI
ACT CAPITAL MANAGEMENT, LLC position in PALI
PALISADE BIO INC · Health Care
ACT CAPITAL MANAGEMENT, LLC reported holding 307,500 shares of PALI (PALISADE BIO INC) in its Q2 2026 13F filing — a position valued at US$643K, representing 0.42% of its reported portfolio and ranking #35 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed PALI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACT CAPITAL MANAGEMENT, LLC's PALI position evolved
ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in PALI in Q4 2025 at 150,000 shares (US$352K). The position peaked in Q2 2026 at 307,500 shares, worth US$643K. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 307,500 shares valued at US$643K — an increase of 50,000 shares quarter over quarter.. Notable position changes include a 72% increase in Q1 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 150.00K | $352.50K | New |
| Q1 2026 | 257.50K | $450.62K | Add |
| Q2 2026 | 307.50K | $642.67K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PALI and 13F data
PALI (PALISADE BIO INC) is a Health Care company. 113 other funds we track also report a position in PALI — the largest reported positions include Soleus Capital Management, L.P. (US$27.3M), B Group, Inc. (US$23.9M), Octagon Capital Advisors LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PALI
- Soleus Capital Management, L.P. 13.06M sh · $27.30M · Q2 2026
- B Group, Inc. 11.41M sh · $23.86M · Q2 2026
- Octagon Capital Advisors LP 10.28M sh · $21.48M · Q2 2026
- Boxer Capital Management, LLC 4.80M sh · $10.03M · Q2 2026
- Squadron Capital Management LLC 3.00M sh · $6.27M · Q2 2026
- Propel Bio Management, LLC 2.58M sh · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.28M sh · $4.78M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 2.26M sh · $4.72M · Q2 2026
- HighVista Strategies LLC 2.03M sh · $4.24M · Q2 2026
- Artia Global Partners LP 1.99M sh · $4.16M · Q2 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 1.73M sh · $3.62M · Q2 2026
- Ally Bridge Group (NY) LLC 1.23M sh · $2.57M · Q2 2026
More on ACT CAPITAL MANAGEMENT, LLC
FAQ
How long has ACT CAPITAL MANAGEMENT, LLC held PALI?
ACT CAPITAL MANAGEMENT, LLC has disclosed PALI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ACT CAPITAL MANAGEMENT, LLC's current position in PALI?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 307.50K shares of PALI (PALISADE BIO INC), valued at $642.67K, representing 0.42% of its reported portfolio and ranking #35.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling PALI?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in PALI. The position peaked in Q2 2026 at 307.50K shares.
Which other funds hold PALI?
Other major institutional holders of PALI include Soleus Capital Management, L.P., B Group, Inc., Octagon Capital Advisors LP, among 113 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.